-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
November 01, 2023 - Eligibility criteria for studies for each Key Question are described in the full report. … Key Question 1 included 111 studies, Key Question 2 included 31 studies, Key
Question 3 included 99 … studies, Key Question 4 included 1 study, and Key Question 5
included 9 studies. … Key Question 2: Health Outcomes. … We also eliminated a Key Question on pharmacogenomics that was in the
original review.
-
effectivehealthcare-admin.ahrq.gov/products/carbohydrate-intake/draft-report
March 01, 2025 - 1) and gestational weight gain (Key Question 2); and between infant digestible carbohydrate intake and … infant growth, size, body composition from birth to 24 months of age (Key Question 3). … infant weight, length, or head circumference or size (small or large for gestational age) at birth (Key Question … gestational weight gain given different amounts of digestible carbohydrate intake during pregnancy (Key Question … head circumference) and body mass index or other body composition outcomes up to 24 months of age (Key Question
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
April 16, 2020 - Public Reviewer 6
Anna Bono
Question 1 Personal anecdote including potentially private information … Public Reviewer 1
Karl Lorenz
Question 2 I find it quite problematic:
That you omit studies of “end … Public Reviewer 4
Jacob Marzalik,
American
Psychological
Association
Question 2 We appreciate the … Public Reviewer 6
Anna Bono
Question 4 Several studies in controlled settings have concluded that … Public Reviewer 7
Anonymous
Question 9 Thank you for this important contribution.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
January 01, 2023 - Agency for Healthcare Research and Quality (Rockville, Maryland, USA). 2023.
22
Key Question 1
What … 23
Key Question 1 – Population and Intervention Targets
Population
Postpartum (≤1 year after giving … group
Nonrandomized comparative studies (NRCSs) N≥30 per group
(prospective or retrospective)
Key Question … 1 – U.S. or Canada only
Key Question 2 – U.S. only
28
Evidence Identified
(92 studies)
Key Question … Key Question 3
What are the comparative effectiveness and harms of alternative magnesium sulfate (MgSO4
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question … Timing: Same as in Question 1
Settings: Same as in Question 1
Question 3: What subset of the population … Timing: Same as in Question 1
Settings: Same as in Question 1
Question 4: What are the potential … Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question … Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question
-
effectivehealthcare-admin.ahrq.gov/products/antidepressants-update/research-protocol
December 01, 2019 - KQ4b:
Key question 4a extends the scope of KQ1c to explore differences between immediate and extended … Exhibit 4-1 below presents the inclusion/exclusion criteria for each key question that we used in the … We will systematically search, review, and analyze the scientific evidence for each key question and … Grading the Evidence for Each Key Question
We will prioritize outcomes of interest for each key question … harms; and key question 5 will also rate comparative harms.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
November 01, 2023 - ACDF in patients with cervical spondylotic radiculopathy or myelopathy at one or
two levels (the Key Question … Main
findings are summarized by Key Question in Table A. … Summary of findings: cervical degenerative disease treatment
Key Question Comparison
Fusion;
Effect … Similar
(++)
AEs:
Moderate to Large,
favors laminoplasty
(+)
5
Key Question … Insufficient
Small,
favoring
PEEK
(+)
No
evidence Insufficient
6
Key Question
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
January 01, 2024 - Key Questions
This systematic review will examine the Key Question as outlined below, based on the … Key Question 1: What are the effects of replacing dietary intake of total or
individual saturated fatty … Key Question 2: What are the effects of replacing dietary intake of total or
individual saturated fatty … 1 only)
o Children and adolescents (for Key
Question 1 only)
o Adults (19-64)
o Older adults (≥ … Review of Key Question
The Joint Canada-U.S.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - For Review Question 2, we will focus on identifying relevant measures that are included in
the Centers … including PSPs used and explanations of the rationale presented in the
studies we find for Review Question … For Review Question 8, we will identify publicly available patient safety toolkits developed
by AHRQ … For Review Question 2, we will focus on identifying relevant measures that are ... … For Review Question 8, we will identify publicly available patient safety toolkits developed by AHRQ
-
effectivehealthcare-admin.ahrq.gov/products/saturated-fat-replacement/protocol
November 01, 2024 - Review of Key Question
VIII. Technical Expert Panel (TEP)
IX. Peer Reviewers
X. … Key Question 1: What are the effects of replacing dietary intake of total or individual saturated fatty … 1 only) Children and adolescents (for Key Question 1 only) Adults (19-64) Older adults (≥65) Pregnant … Key Question 2 Minimum follow-up If population has no CV risk factors: 10 years If population has one … Review of Key Question
The Joint Canada-U.S.
-
effectivehealthcare-admin.ahrq.gov/products/schizophrenia-adult/research-protocol
September 01, 2019 - Key Question 1a What are the comparative benefits and harms of pharmacological treatments for adults … Key Question 2a What are the benefits and harms of psychosocial and other non-pharmacological treatments … (and include all eligible interventions for the key question), include studies that meet the PICOTS … For Key Question 2 on nonpharmacological interventions, search dates will not be restricted. … As there are large, high quality systematic reviews of the interventions in Key Question 1 that have
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-treatment-localized-muscle-invasive-bladder-cancer
November 01, 2020 - Does your question include a comparison of different health care approaches? … Are there subgroups of patients that your question might apply to? … (National Cancer Institute 2010
What specifically motivated you to ask this question? … Additional patient and medical prov
Does your question represent uncertainty for clinicians and/or … Describe the timeframe in which an answer to your question is needed.
The AUA is flexible.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/delilberative-methods-design-gupta-2.pdf
January 11, 2017 - and establish
priorities for action
Slide 24
Six Facilitator Choices
As a “reaction” question … As a new starting question
Let there be silence
Move on
Paraphrase
Ask a “probing” or … “follow-up” question
Slide 25
Planning Considerations
Who will you ask to facilitate deliberation
-
effectivehealthcare-admin.ahrq.gov/products/adhd/research-protocol
December 01, 2019 - This question was added to the review.
a. … Question 2. … Question 3. … PICO table for ADHD Review
PICO
Question 1
Question 2
Question 3
Population … For question three, we will also include cross-sectional reports.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-241-physical-activity-wheelchair-evidence-summary-updated.pdf
October 01, 2021 - Key Question 1: Prevention of Cardiovascular Conditions,
Diabetes, and Obesity
No included study … Key Question 2: Benefits and Harms
Compared with no physical activity or usual care, physical activity … https://effectivehealthcare.ahrq.gov/topics/cer-methods-guide/overview
3
Key Question … 1: Prevention of Cardiovascular Conditions, Diabetes, and Obesity
Key Question 2: Benefits and Harms … Key Question 3: Patient Factors Affecting Benefits and Harms
Limitations
Key Question 4: Methodological
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
January 01, 2024 - Key Question 1: What are the effects of different dietary polyunsaturated
fatty acid intake on plasma … 1
● Children and adults
Key Question 2
● Adults (≥18 years old)
Both Key Questions
● Participants … 1 only)
o Children and adolescents (for Key
Question 1 only)
o Adults (19-64)
o Older adults (≥ … Key Question 2
● Minimum follow-up
o If population has no CV risk factors
(or unselected general … Review of Key Question
The Joint Canada-U.S.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
October 12, 2020 - It is quite likely that there are
insufficient data to answer this question,
but it seems like a question … related to diet
may be worth considering under this key
question. … Unfortunately, this was not included in the
protocol as a Key Question of interest. … KI
and TEP discussions did not raise this as
a Key Question to add. … Key Question 2b (p.24): As with Key
Question 2a, we suggest checking for
consistency in how findings
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_facilitation.pdf
May 18, 2012 - common
ground and establish priorities for action
2
Six Facilitator Choices
Ask a “reaction” question … Ask a new starting question
Let there be silence
Move on
Paraphrase
Ask a “probing” or “follow-up … ”
question
3
Planning Considerations
• Who will you ask to facilitate deliberation?
-
effectivehealthcare-admin.ahrq.gov/products/polyunsaturated-fatty/protocol
November 01, 2024 - Review of Key Question
VIII. Technical Expert Panel (TEP)
IX. Peer Reviewers
X. … Key Question 1: What are the effects of different dietary polyunsaturated fatty acid intake on plasma … 1 only) Children and adolescents (for Key Question 1 only) Adults (19-64) Older adults (≥65) Pregnant … Key Question 2 Minimum follow-up If population has no CV risk factors (or unselected general population … Review of Key Question
The Joint Canada-U.S.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/strategies-integrating-behavioral-health-protocol.pdf
August 04, 2022 - Key Question (2) and Sub-question 5a. … Scan Question. … Key Question (2) and Question 5a. … (Question 5). … Key Question 2 and Question 5a.